Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSUVA-30: Low vs High Dose Rosuvastatin in Post-PCI CAD
NCT02859480Phase 4Unknown
- Sponsor
- Korea University Anam Hospital
- Start
- Sep 2015
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in coronary artery disease (CAD), sponsored by Korea University Anam Hospital. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02859480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02859480.